Inventor

LUSTENBERGER PHILIPP

CH50 patents

⚠️ This page may combine multiple inventors who share the name “LUSTENBERGER PHILIPP”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

LUSTENBERGER PHILIPP

BOEHRINGER INGELHEIM INT

Selected CGRP—antagonists, process for preparing them and their use as pharmaceutical compositions

CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Enantiomerically pure beta agonists, process for the manufacture thereof, and use thereof as medicaments

Long acting beta-2-agonists and their use as medicaments

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments

Long acting β-2-agonists and their use as medicaments

Amide compounds with MCH antagonistic activity and medicaments comprising these compounds

Betamimetics for the treatment of respiratory complaints

Beta agonists for the treatment of respiratory diseases

Selected CGRP-antagonists process for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Enantiomerically pure beta agonists, process for the manufacture thereof and use thereof as medicaments

Long acting beta-2-agonists and their use as medicaments

Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions

Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions

Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions

CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists, processes for preparing them and their use as pharmaceutical compositions

Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions

Long acting bronchodilators for the treatment of respiratory diseases

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

β-ketoamide compounds with MCH antagonistic activity

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

Substituted cycloalkyl derivatives, process for the manufacture thereof and use thereof as medicament

Selected CGRP-antagonists, process for preparing them and their use as pharmaceutical compositions

BOEHRINGER INGELHEIM PHARMA

Medicaments for the treatment of chronic obstructive pulmonary disease

Medicaments for the treatment of chronic obstructive pulmonary disease

Amide compounds having MCH-antagonistic activity and medicaments comprising these compounds

Medicaments for the treatment of chronic obstructive pulmonary disease

Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof

Medicaments for the treatment of chronic obstructive pulmonary disease

Selected CGRP antagonists, processes for preparing them and their use as pharmaceutical compositions

Substituted piperidines, pharmaceutical compositions containing these compounds, their use and processes for the preparation thereof

CGRP antagonists

NOVARTIS AG

Crystalline form of LNP023

Crystalline form of LNP023

Benzothiazolone compound

Benzothiazolone compound

Crystalline forms of a TLR7/TLR8 inhibitor

Process for preparing 1-(4-methanesulfonyl-2-trifluoromethyl-benzyl)-2-methyl-1H-pyrrolo [2,3-B]pyridin-3-yl-acetic acid

CAO JUN

Benzothiazolone compound

STENKAMP DIRK

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

KUESTERS ERNST

Processes for the preparation of 4-oxo-octahydro-indole-1-carbocyclic acid methyl ester and derivatives thereof

LUSTENBERGER PHILIPP

Process for preparing 1-(4-methanesulfonyl-2-trifluoromethyl-benzyl)-2-methyl-1H-pyrrolo [2,3-B]pyridin-3-yl-acetic acid